Blueprint Medicines News

9 Health Care Stocks Whale Activity In Today's Session

BenzingaAug 13 13:35 ET

10 Health Care Stocks Whale Activity In Today's Session

BenzingaAug 8 13:35 ET

Guolian Securities: Increased attention to tumor immunology, recommend focusing on targeted drugs such as PD1/IL2 in pharmaceutical companies.

With the increasing attention to tumor immunity, and the successive launch of advantageous products, bullish on PD1/IL2 and PD1/IL15 targeted drugs.

Zhitong FinanceAug 8 02:55 ET

Blueprint Medicines Insider Sold Shares Worth $3,905,872, According to a Recent SEC Filing

MT NewswiresAug 7 17:13 ET

Analysts Just Shipped A Sizeable Upgrade To Their Blueprint Medicines Corporation (NASDAQ:BPMC) Estimates

Yahoo FinanceAug 7 08:02 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Blueprint Medicines (BPMC), Adaptimmune Therapeutics (ADAP) and Ardelyx (ARDX)

TipRanksAug 7 01:54 ET · Ratings

Form 144 | Blueprint Medicines(BPMC.US) Officer Proposes to Sell 4.32 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Aug 5, $Blueprint Medicines(BPMC.US)$ Officer Lee Philina intends to sell 46,436 shares of its common stock on Aug 5, with a total market value of approximately $4.32 million.

Moomoo NewsAug 5 16:54 ET

Needham Maintains Buy on Blueprint Medicines, Raises Price Target to $133

BenzingaAug 5 15:13 ET · Ratings

TD Cowen Maintains Blueprint Medicines(BPMC.US) With Buy Rating

Moomoo NewsAug 5 07:33 ET · Ratings

Barclays Maintains Blueprint Medicines(BPMC.US) With Hold Rating, Raises Target Price to $105

Moomoo NewsAug 5 04:32 ET · Ratings

Blueprint Medicines (BPMC) Receives a Hold From Barclays

TipRanksAug 5 03:46 ET · Ratings

Blueprint Medicines Second Quarter 2024 Earnings: Beats Expectations

Yahoo FinanceAug 3 09:10 ET

Blueprint Medicines Is Maintained at Buy by Guggenheim

Dow JonesAug 2 15:19 ET

Blueprint Medicines Price Target Raised to $138.00/Share From $130.00 by Guggenheim

Dow JonesAug 2 15:19 ET · Ratings

Express News | Baird Maintains Outperform on Blueprint Medicines, Raises Price Target to $127

BenzingaAug 2 10:44 ET

Blueprint Medicines (BPMC) Down Despite Q2 Earnings Beat

Zacks Aug 2 09:50 ET

A Quick Look at Today's Ratings for Blueprint Medicines(BPMC.US), With a Forecast Between $120 to $135

Moomoo NewsAug 2 09:00 ET · Ratings

Express News | Blueprint Medicines Corp : Needham Raises Target Price to $133.00 From $130.00

ReutersAug 2 06:39 ET

Express News | Blueprint Medicines Corp : Piper Sandler Raises Target Price to $109 From $104

ReutersAug 2 04:13 ET

Blueprint Medicines: A Strong Buy on Impressive Financials and Promising Growth Trajectory

TipRanksAug 2 00:46 ET